Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
The top astronomical discoveries of 2025- 10 High priority Contraptions for Tech Aficionados
- Old age isn’t a modern phenomenon – many people lived long enough to grow old in the olden days, too
- Elanco's drug gets emergency nod to treat deadly flesh-eating parasite in cats
- 2025 among world's three hottest years on record, WMO says
- 'A prank': Israel Police detain suspect for shooting rubber bullets at Ashkelon kindergarten
- FBI arrests Brian Cole Jr. in Jan. 6 pipe bomb investigation, ending 5-year hunt
- Toyota Reports 2.3% Sales Drop as China Weakness Deepens
- How the Iran war may affect your money and bills
